13 Head and Neck - Oropharynx

Head and Neck - Oropharynx

24

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 15/02/2021

Oncol Biol Phys 1994;30:1051–7. https://doi.org/10.1016/0360-3016(94)90309-3. 36. Kovács G, Martinez-Monge R, Budrukkar A, Guinot JL, Johansson B, Strnad V, et al. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology. Radiother Oncol J Eur SocTher Radiol Oncol 2017;122:248–54. https://doi.org/10.1016/j. radonc.2016.10.008. 37. Cano ER, Lai SY, Caylakli F, Johnson JT, Ferris RL, Carrau RL, et al. Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy. Head Neck 2009;31:1431–8. https://doi.org/10.1002/hed.21111. 38. Takácsi-Nagy Z, Martínez-Mongue R, Mazeron J-J, Anker CJ, Harrison LB. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumours and other head and neck sites in the era of new technologies. Brachytherapy 2017;16:44–58. https://doi.org/10.1016/j.brachy.2016.07.005. 39. Bhalavat R, Chandra M, Pareek V, Nellore L, George K, Nandakumar P, et al. High-dose-rate interstitial brachytherapy in head and neck cancer: do we need a look back into a forgotten art - a single institute experience. J Contemp Brachytherapy 2017;9:124–31. https://doi.org/10.5114/jcb.2017.67147. 40. Lusinchi A, Eskandari J, Son Y, Gerbaulet A, Haie C, Mamelle G, et al. External irradiation plus curietherapy boost in 108 base of tongue carcinomas. Int J Radiat Oncol Biol Phys 1989;17:1191–7. https://doi.org/10.1016/0360-3016(89)90525-7. 41. Crook J, Mazeron JJ, MarinelloG, MartinM, Raynal M, Calitchi E, et al. Combined external irradiation and interstitial implantation for T1 and T2 epidermoid carcinomas of base of tongue: the Creteil experience (1971-1981). Int J Radiat Oncol Biol Phys 1988;15:105–14. https://doi.org/10.1016/0360-3016(88)90353-7. 42. Regueiro CA, Millán I, de la Torre A, Valcárcel FJ, Magallón R, Fernández E, et al. Influence of boost technique (external beam radiotherapy or brachytherapy) on the outcome of patients with carcinoma of the base of the tongue. Acta Oncol Stockh Swed 1995;34:225–33. https://doi.org/10.3109/02841869509093960. 43. Mazeron JJ, Gerbaulet A, Simon JM, Hardiman C. How to optimize therapeutic ratio in brachytherapy of head and neck squamous cell carcinoma? Acta Oncol Stockh Swed 1998;37:583–91. 44. Esche BA, Haie CM, Gerbaulet AP, Eschwege F, Richard JM, Chassagne D. Interstitial and external radiotherapy in carcinoma of the soft palate and uvula. Int J Radiat Oncol Biol Phys 1988;15:619–25. https://doi.org/10.1016/0360- 3016(88)90303-3. 45. Haddad A, Peiffert D, Lapeyre M, Harter V, Buchheit I, Graff P. A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy. Brachytherapy 2014;13:597–602. https://doi.org/10.1016/j.brachy.2014.05.011. 46. Mohanti BK, Sahai P,Thakar A, Sikka K, Bhasker S, Sharma A, et al. Institutional experience of interstitial brachytherapy for head and neck cancer with a comparison of high- and low dose rate practice. Asian Pac J Cancer Prev APJCP 2014;15:813–8. 47. Nose T, Koizumi M, Nishiyama K. High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 2004;59:983–91. https://doi.org/10.1016/j.ijrobp.2003.12.015. 48. Takácsi-Nagy Z, Oberna F, Koltai P, Hitre E, Major T, Fodor J, et al. Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer. Brachytherapy 2013;12:535–41. https://doi.org/10.1016/j. brachy.2013.07.001. 49. Rudoltz MS, Perkins RS, Luthmann RW, Fracke TD, Green TM, Moye L, et al. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx. The Laryngoscope 1999;109:1967–73. https://doi. org/10.1097/00005537-199912000-00013. 50. Martínez-Fernández MI, Alcalde J, CambeiroM, Peydró GV, Martínez-Monge R. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study. Radiother Oncol J Eur Soc Ther Radiol Oncol 2017;122:255–9. https://doi.org/10.1016/j. radonc.2016.08.023. 51. Martínez-Monge R, Gómez-Iturriaga A, CambeiroM, Garrán C, Montesdeoca N, Aristu JJ, et al. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer. Brachytherapy 2009;8:26–33. https:// doi.org/10.1016/j.brachy.2008.10.002. 52. Martínez-Monge R, CambeiroM, Ramos LI, Olarte A, Valtueña G, San-JuliánM, et al. Volume of high-dose regions and likelihood of locoregional control after

perioperative high-dose-rate brachytherapy: do hotter implants work better? Brachytherapy 2014;13:591–6. https://doi.org/10.1016/j.brachy.2014.05.015. 53. Martínez-Monge R, Pagola Divassón M, Cambeiro M, Gaztañaga M, Moreno M, Arbea L, et al. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB). Int J Radiat Oncol Biol Phys 2011;81:e245-254. https://doi.org/10.1016/j.ijrobp.2011.03.026. 54. VikramB, Hilaris BS, Anderson L, Strong EW. Permanent Iodine-125 implants in head and neck cancer. Cancer 1983;51:1310–4. https://doi.org/10.1002/1097- 0142(19830401)51:7<1310::aid-cncr2820510722>3.0.co;2-i. 55. Stannard C, Maree G, Tovey S, Hunter A, Wetter J. Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx. Brachytherapy 2014;13:405–12. https://doi.org/10.1016/j.brachy.2014.02.443. 56. Horwitz EM, Frazier AJ, Martinez AA, Keidan RD, Clarke DH, Lacerna MD, et al. Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost. Cancer 1996;78:948–57. https://doi.org/10.1002/(SICI)1097- 0142(19960901)78:5<948::AID-CNCR3>3.0.CO;2-8. 57. Jiang P, Wang J, RanW, Jiang Y, Tian S, SunH. Five-year outcome of ultrasound- guided interstitial permanent 125I seeds implantation for local head and neck recurrent tumours: a single center retrospective study. J Contemp Brachytherapy 2019;11:28–34. https://doi.org/10.5114/jcb.2019.83336. 58. Peiffert D, Pernot M, Malissard L, Aletti P, Hoffstetter S, Kozminski P, et al. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys 1994;29:681–6. https://doi.org/10.1016/0360-3016(94)90554-1. 59. Mazeron JJ, Langlois D, Glaubiger D, Huart J, MartinM, Raynal M, et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys 1987;13:957–62. https://doi. org/10.1016/0360-3016(87)90031-9. 60. Strnad V, LotterM, Kreppner S, Fietkau R. Re-irradiation with interstitial pulsed- dose-rate brachytherapy for unresectable recurrent head and neck carcinoma. Brachytherapy 2014;13:187–95. https://doi.org/10.1016/j.brachy.2013.10.008. 61. Bhalavat R, Pareek V, Chandra M, Nellore L, George K, Borade D, et al. High- dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option. J Contemp Brachytherapy 2018;10:425–30. https:// doi.org/10.5114/jcb.2018.78995. 62. Hepel JT, Syed AMN, Puthawala A, Sharma A, Frankel P. Salvage high-dose- rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;62:1444–50. https://doi.org/10.1016/j.ijrobp.2004.12.078. 63. Narayana A, Cohen GN, Zaider M, Chan K, Lee N, Wong RJ, et al. High-dose- rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results. Brachytherapy 2007;6:157–63. https://doi. org/10.1016/j.brachy.2006.12.001. 64. Lee N. Counterpoint: brachytherapy versus intensity-modulated radiation therapy in the management of base of tongue cancers. Brachytherapy 2005;4:5–7; discussion 8-9. https://doi.org/10.1016/j.brachy.2004.10.005. 65. Budrukkar A. A randomised trial comparing modulated external beam radiation alone vs intensity modulated radiation and brachytherapy for reduction in xerostomia in patients with early staged oropharyngeal cancers. CTRI/2010/091/001329 n.d.